LexDanaLexDanabeta
Inventor

Bradley R. PEARSE

Inventor
US

Overview

4→
Patents
2023–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
Y02ATechnologies for adaptation to climate change14%
PatentTitleYear
12,291,576Anti-CD45 antibodies and conjugates thereof202512,209,135Anti-CD45 antibodies and conjugates thereof202511,958,908Compositions and methods for the depletion of CD117+ cells202411,572,411Anti-CD117 antibodies and conjugates2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to MAGENTA THERAPEUTICS INC (1)· patent assignee history
2023–2025Based in US· patent location history
2024Patents assigned to CRISPR THERAPEUTICS AG (1)· patent assignee history
2025Patents assigned to VOR BIOPHARMA INC (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VOR BIOPHARMA INC22025
CRISPR THERAPEUTICS AG12024
MAGENTA THERAPEUTICS INC12023
Locations
LocationPatentsSpan
US42023–2025